M D Iseman. Show Affiliations »
Abstract
Mesh: See more » Antitubercular Agents/therapeutic useDrug CombinationsHumansIsoniazid/therapeutic usePyrazinamide/therapeutic useRifampin/therapeutic useTuberculosis, Pulmonary/drug therapy
Substances: See more » Antitubercular AgentsDrug Combinationsisoniazid, pyrazinamide, rifampin drug combinationPyrazinamideIsoniazidRifampin
Year: 1999 PMID: 10091871
Source DB: PubMed Journal: Int J Tuberc Lung Dis ISSN: 1027-3719 Impact factor: 2.373